Supplemental Evidence and Data Request on Trauma Informed Care, 75285-75286 [2023-24214]
Download as PDF
Federal Register / Vol. 88, No. 211 / Thursday, November 2, 2023 / Notices
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than December 4, 2023.
A. Federal Reserve Bank of Boston
(Prabal Chakrabarti, Senior Vice
President) 600 Atlantic Avenue, Boston,
Massachusetts 02210–2204. Comments
can also be sent electronically to
BOS.SRC.Applications.Comments@
bos.frb.org:
1. Mutual Bancorp MHC, Hyannis,
Massachusetts; to merge with Fidelity
Mutual Holding Company Leominster,
Massachusetts, and thereby indirectly
acquire Life Design Holding Company,
Hyannis, Massachusetts, and Fidelity
Co-Operative Bank, Leominster,
Massachusetts.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023–24243 Filed 11–1–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Supplemental Evidence and Data
Request on Trauma Informed Care
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for supplemental
evidence and data submission.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review on
Trauma Informed Care, which is
currently being conducted by the
AHRQ’s Evidence-based Practice
Centers (EPC) Program. Access to
published and unpublished pertinent
scientific information will improve the
quality of this review.
DATES: Submission Deadline on or
before December 4, 2023.
ADDRESSES:
Email submissions: epc@ahrq.hhs.gov
Print submissions:
Mailing Address: Center for Evidence
and Practice Improvement, Agency for
Healthcare Research and Quality,
ATTN: EPC SEADs Coordinator, 5600
Fishers Lane, Mail Stop 06E53A,
Rockville, MD 20857.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:32 Nov 01, 2023
Jkt 262001
Shipping Address (FedEx, UPS, etc.):
Center for Evidence and Practice
Improvement, Agency for Healthcare
Research and Quality, ATTN: EPC
SEADs Coordinator, 5600 Fishers Lane,
Mail Stop 06E77D, Rockville, MD
20857.
FOR FURTHER INFORMATION CONTACT:
Kelly Carper, Telephone: 301–427–1656
or Email: epc@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Trauma Informed Care.
AHRQ is conducting this review
pursuant to Section 902 of the Public
Health Service Act, 42 U.S.C. 299a.
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Trauma Informed Care.
The entire research protocol is available
online at: https://effectivehealthcare.
ahrq.gov/products/trauma-informedcare/protocol.
This is to notify the public that the
EPC Program would find the following
information on Trauma Informed Care
helpful:
D A list of completed studies that
your organization has sponsored for this
topic. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov, a
summary, including the following
elements, if relevant: study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to follow-up/withdrawn/
analyzed, effectiveness/efficacy, and
safety results.
D A list of ongoing studies that your
organization has sponsored for this
topic. In the list, please provide the
ClinicalTrials.gov trial number or, if the
trial is not registered, the protocol for
the study including, if relevant, a study
number, the study period, design,
methodology, indication and diagnosis,
proper use instructions, inclusion and
exclusion criteria, and primary and
secondary outcomes.
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
75285
D Description of whether the above
studies constitute ALL Phase II and
above clinical trials sponsored by your
organization for this topic and an index
outlining the relevant information in
each submitted file.
Your contribution is very beneficial to
the Program. Materials submitted must
be publicly available or able to be made
public. Materials that are considered
confidential; marketing materials; study
types not included in the review; or
information on topics not included in
the review cannot be used by the EPC
Program. This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter.
The draft of this review will be posted
on AHRQ’s EPC Program website and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
https://www.effectivehealthcare.
ahrq.gov/email-updates.
The review will answer the following
questions. This information is provided
as background. AHRQ is not requesting
that the public provide answers to these
questions.
Key Questions (KQ)
TIC for Adult Patients/Clients
• KQ 1. What is the evidence of
benefits and/or harms of TIC on
outcomes for patients/clients?
Æ KQ 1a. Which components (e.g.,
education and training of providers about
trauma, screening patients, delivering pointof-care interventions [note this is not meant
to include established evidence-based
treatments for trauma-related disorders],
referring patients/clients for various forms of
additional assessment and treatment for
indicated needs) of TIC models, and
organizational and practice characteristics,
are associated with benefits and/or harms?
Æ KQ 1b. Do outcomes vary by patient/
client or clinical or organizational
characteristics, including the nature, extent
and timing of exposure (e.g., recent or
ongoing vs. prior exposure in childhood)?
TIC for Child and Adolescent Patients/
Clients
• KQ 2. What is the evidence of
benefits and/or harms of TIC on
outcomes for patients/clients?
Æ KQ 2a. Which components (e.g.,
education and training of providers about
trauma, screening patients, delivering pointof-care interventions [note this is not meant
to include indicated evidence-based
treatments for trauma-related disorders],
referring clients for various forms of
additional assessment and treatment for
indicated needs) of TIC models,
organizational and practice characteristics,
are associated with benefits and/or harms?
E:\FR\FM\02NON1.SGM
02NON1
75286
Federal Register / Vol. 88, No. 211 / Thursday, November 2, 2023 / Notices
Æ KQ 2b. Do outcomes vary by patient/
client (as well as parent) or clinical or
organizational characteristics including the
nature, extent, and timing of exposure (e.g.,
recent or ongoing vs. prior exposure)?
PICOTS (POPULATIONS, INTERVENTIONS, COMPARATORS, OUTCOMES, TIMING, AND SETTING)
PICOTS
Population ............................
Intervention ..........................
Comparator ..........................
Outcome ...............................
Timing ..................................
Setting ..................................
KQ1
Adults 18 years and older, regardless of trauma exposure.
1b. Patient/client and clinical characteristics including
type, time since, and duration of trauma exposure;
gender; race/ethnicity; age; clinical condition; or disorder (e.g., anxiety, depression, substance use).
TIC models/components of care (e.g., education and
training of providers about trauma, screening patients/clients for trauma exposure using ACEs or
other tools, screening for symptoms, delivering pointof-care interventions, referring patients/clients for various forms of additional assessment and treatment
for indicated needs).
1a. single or multi-component, individual or group, targeting organizations, providers, patients/clients, caregivers, or a combination, training, screening.
No TIC model of care/usual or routine care (CAU) ........
Other TIC model or component(s) of care, evidencebased therapies for trauma-related conditions (e.g.,
prolonged exposure, cognitive processing therapy) or
approaches (e.g., Collaborative Care).
Trauma-Specific: Additional or repeat trauma exposure
from the point-of-care in the course of care/service
delivery (e.g., retraumatization).
Process outcomes: Health care outcomes/utilization/referral, provider burnout/mental health.
Organizational/practice/systems outcomes: Intake and
referral processes (e.g., wait times), disseminated
policies, trainings, staffing (e.g., scribes), administrative requirements, access to treatment, workforce diversity.
Patient/client-centered outcomes: Physical and mental
health outcomes, functioning, clinical improvement,
patient/client engagement, trust, comfort or satisfaction, and strengths-based outcomes (e.g., quality of
life).
Harms: Includes displacement of evidence based care
(e.g., screening for anxiety, depression, substance
use, suicide risk), increase in patient/client aggression or other behavioral misconduct.
Any ..................................................................................
Routine or emergency healthcare in any setting that
provides human or social services, including in nontraditional settings (e.g., HIV clinics providing behavioral health care).
Dated: October 27, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–24214 Filed 11–1–23; 8:45 am]
khammond on DSKJM1Z7X2PROD with NOTICES
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
VerDate Sep<11>2014
16:32 Nov 01, 2023
KQ2
Jkt 262001
Youth <18 years, regardless of trauma exposure.
2b. Patient/client and clinical characteristics including
type, time since, and duration of trauma exposure;
gender; race/ethnicity; age; clinical condition; or disorder, (e.g., anxiety, depression, ADHD, conduct disorder, substance use).
TIC models/components of care (e.g., education and
training of providers about trauma, screening patients/clients for trauma exposure using ACEs or
other tools, screening for symptoms, delivering point
of care interventions, referring patients/clients for various forms of additional assessment and treatment
for indicated needs).
2a. single or multi-component, individual or group, targeting organizations, providers, patients/clients, caregivers, or a combination, training, screening.
No TIC model of care/usual or routine care (CAU).
Other TIC model or component(s) of care, evidencebased therapies for trauma-related conditions (e.g.,
trauma-focused CBT) or approaches (e.g., Collaborative Care).
Trauma-Specific: Additional or repeat trauma exposure
from the point-of-care in the course of care/service
delivery (e.g., retraumatization).
Process outcomes: Healthcare outcomes/utilization/referral, provider outcomes burnout/mental health.
Organizational/practice/systems outcomes: Intake and
referral processes (e.g., wait times), disseminated
policies, trainings, staffing (e.g., scribes), administrative requirements, access to treatment, workforce diversity, anti-racism principles.
Patient/client-centered outcomes: Physical and mental
health outcomes, functioning, clinical improvement,
patient/client engagement, trust, comfort or satisfaction, and strengths-based outcomes (e.g., quality of
life).
Harms: Includes displacement of evidence based care
(e.g., screening for developmental milestones,
ADHD, depression, anxiety, suicide risk, substance
use), increase in patient/client aggression or other
behavioral misconduct.
Any.
Routine or emergency healthcare in any setting that
provides human or social services, including in nontraditional settings (e.g., school-based clinics providing behavioral health care).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
TS24–010, Identify and Evaluate
Potential Risk Factors for Amyotrophic
Lateral Sclerosis (ALS).
Date: April 9, 2024.
Time: 8:30 a.m.–5 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Mikel L. Walters, Ph.D., Scientific
Review Officer, National Center for
E:\FR\FM\02NON1.SGM
02NON1
Agencies
[Federal Register Volume 88, Number 211 (Thursday, November 2, 2023)]
[Notices]
[Pages 75285-75286]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24214]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Supplemental Evidence and Data Request on Trauma Informed Care
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Request for supplemental evidence and data submission.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is
seeking scientific information submissions from the public. Scientific
information is being solicited to inform our review on Trauma Informed
Care, which is currently being conducted by the AHRQ's Evidence-based
Practice Centers (EPC) Program. Access to published and unpublished
pertinent scientific information will improve the quality of this
review.
DATES: Submission Deadline on or before December 4, 2023.
ADDRESSES:
Email submissions: [email protected]
Print submissions:
Mailing Address: Center for Evidence and Practice Improvement,
Agency for Healthcare Research and Quality, ATTN: EPC SEADs
Coordinator, 5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857.
Shipping Address (FedEx, UPS, etc.): Center for Evidence and
Practice Improvement, Agency for Healthcare Research and Quality, ATTN:
EPC SEADs Coordinator, 5600 Fishers Lane, Mail Stop 06E77D, Rockville,
MD 20857.
FOR FURTHER INFORMATION CONTACT: Kelly Carper, Telephone: 301-427-1656
or Email: [email protected].
SUPPLEMENTARY INFORMATION: The Agency for Healthcare Research and
Quality has commissioned the Evidence-based Practice Centers (EPC)
Program to complete a review of the evidence for Trauma Informed Care.
AHRQ is conducting this review pursuant to Section 902 of the Public
Health Service Act, 42 U.S.C. 299a.
The EPC Program is dedicated to identifying as many studies as
possible that are relevant to the questions for each of its reviews. In
order to do so, we are supplementing the usual manual and electronic
database searches of the literature by requesting information from the
public (e.g., details of studies conducted). We are looking for studies
that report on Trauma Informed Care. The entire research protocol is
available online at: https://effectivehealthcare.ahrq.gov/products/trauma-informed-care/protocol.
This is to notify the public that the EPC Program would find the
following information on Trauma Informed Care helpful:
[ssquf] A list of completed studies that your organization has
sponsored for this topic. In the list, please indicate whether results
are available on ClinicalTrials.gov along with the ClinicalTrials.gov
trial number.
[ssquf] For completed studies that do not have results on
ClinicalTrials.gov, a summary, including the following elements, if
relevant: study number, study period, design, methodology, indication
and diagnosis, proper use instructions, inclusion and exclusion
criteria, primary and secondary outcomes, baseline characteristics,
number of patients screened/eligible/enrolled/lost to follow-up/
withdrawn/analyzed, effectiveness/efficacy, and safety results.
[ssquf] A list of ongoing studies that your organization has
sponsored for this topic. In the list, please provide the
ClinicalTrials.gov trial number or, if the trial is not registered, the
protocol for the study including, if relevant, a study number, the
study period, design, methodology, indication and diagnosis, proper use
instructions, inclusion and exclusion criteria, and primary and
secondary outcomes.
[ssquf] Description of whether the above studies constitute ALL
Phase II and above clinical trials sponsored by your organization for
this topic and an index outlining the relevant information in each
submitted file.
Your contribution is very beneficial to the Program. Materials
submitted must be publicly available or able to be made public.
Materials that are considered confidential; marketing materials; study
types not included in the review; or information on topics not included
in the review cannot be used by the EPC Program. This is a voluntary
request for information, and all costs for complying with this request
must be borne by the submitter.
The draft of this review will be posted on AHRQ's EPC Program
website and available for public comment for a period of 4 weeks. If
you would like to be notified when the draft is posted, please sign up
for the email list at: https://www.effectivehealthcare.ahrq.gov/email-updates.
The review will answer the following questions. This information is
provided as background. AHRQ is not requesting that the public provide
answers to these questions.
Key Questions (KQ)
TIC for Adult Patients/Clients
KQ 1. What is the evidence of benefits and/or harms of TIC
on outcomes for patients/clients?
[cir] KQ 1a. Which components (e.g., education and training of
providers about trauma, screening patients, delivering point-of-care
interventions [note this is not meant to include established
evidence-based treatments for trauma-related disorders], referring
patients/clients for various forms of additional assessment and
treatment for indicated needs) of TIC models, and organizational and
practice characteristics, are associated with benefits and/or harms?
[cir] KQ 1b. Do outcomes vary by patient/client or clinical or
organizational characteristics, including the nature, extent and
timing of exposure (e.g., recent or ongoing vs. prior exposure in
childhood)?
TIC for Child and Adolescent Patients/Clients
KQ 2. What is the evidence of benefits and/or harms of TIC
on outcomes for patients/clients?
[cir] KQ 2a. Which components (e.g., education and training of
providers about trauma, screening patients, delivering point-of-care
interventions [note this is not meant to include indicated evidence-
based treatments for trauma-related disorders], referring clients
for various forms of additional assessment and treatment for
indicated needs) of TIC models, organizational and practice
characteristics, are associated with benefits and/or harms?
[[Page 75286]]
[cir] KQ 2b. Do outcomes vary by patient/client (as well as
parent) or clinical or organizational characteristics including the
nature, extent, and timing of exposure (e.g., recent or ongoing vs.
prior exposure)?
PICOTS (Populations, Interventions, Comparators, Outcomes, Timing, and
Setting)
------------------------------------------------------------------------
PICOTS KQ1 KQ2
------------------------------------------------------------------------
Population.................. Adults 18 years and Youth <18 years,
older, regardless regardless of
of trauma exposure. trauma exposure.
1b. Patient/client 2b. Patient/client
and clinical and clinical
characteristics characteristics
including type, including type,
time since, and time since, and
duration of trauma duration of trauma
exposure; gender; exposure; gender;
race/ethnicity; race/ethnicity;
age; clinical age; clinical
condition; or condition; or
disorder (e.g., disorder, (e.g.,
anxiety, anxiety,
depression, depression, ADHD,
substance use). conduct disorder,
substance use).
Intervention................ TIC models/ TIC models/
components of care components of care
(e.g., education (e.g., education
and training of and training of
providers about providers about
trauma, screening trauma, screening
patients/clients patients/clients
for trauma exposure for trauma exposure
using ACEs or other using ACEs or other
tools, screening tools, screening
for symptoms, for symptoms,
delivering point-of- delivering point of
care interventions, care interventions,
referring patients/ referring patients/
clients for various clients for various
forms of additional forms of additional
assessment and assessment and
treatment for treatment for
indicated needs). indicated needs).
1a. single or multi- 2a. single or multi-
component, component,
individual or individual or
group, targeting group, targeting
organizations, organizations,
providers, patients/ providers, patients/
clients, clients,
caregivers, or a caregivers, or a
combination, combination,
training, screening. training,
screening.
Comparator.................. No TIC model of care/ No TIC model of care/
usual or routine usual or routine
care (CAU). care (CAU).
Other TIC model or Other TIC model or
component(s) of component(s) of
care, evidence- care, evidence-
based therapies for based therapies for
trauma-related trauma-related
conditions (e.g., conditions (e.g.,
prolonged exposure, trauma-focused CBT)
cognitive or approaches
processing therapy) (e.g.,
or approaches Collaborative
(e.g., Care).
Collaborative Care).
Outcome..................... Trauma-Specific: Trauma-Specific:
Additional or Additional or
repeat trauma repeat trauma
exposure from the exposure from the
point-of-care in point-of-care in
the course of care/ the course of care/
service delivery service delivery
(e.g., (e.g.,
retraumatization). retraumatization).
Process outcomes: Process outcomes:
Health care Healthcare outcomes/
outcomes/ utilization/
utilization/ referral, provider
referral, provider outcomes burnout/
burnout/mental mental health.
health.
Organizational/ Organizational/
practice/systems practice/systems
outcomes: Intake outcomes: Intake
and referral and referral
processes (e.g., processes (e.g.,
wait times), wait times),
disseminated disseminated
policies, policies,
trainings, staffing trainings, staffing
(e.g., scribes), (e.g., scribes),
administrative administrative
requirements, requirements,
access to access to
treatment, treatment,
workforce diversity. workforce
diversity, anti-
racism principles.
Patient/client- Patient/client-
centered outcomes: centered outcomes:
Physical and mental Physical and mental
health outcomes, health outcomes,
functioning, functioning,
clinical clinical
improvement, improvement,
patient/client patient/client
engagement, trust, engagement, trust,
comfort or comfort or
satisfaction, and satisfaction, and
strengths-based strengths-based
outcomes (e.g., outcomes (e.g.,
quality of life). quality of life).
Harms: Includes Harms: Includes
displacement of displacement of
evidence based care evidence based care
(e.g., screening (e.g., screening
for anxiety, for developmental
depression, milestones, ADHD,
substance use, depression,
suicide risk), anxiety, suicide
increase in patient/ risk, substance
client aggression use), increase in
or other behavioral patient/client
misconduct. aggression or other
behavioral
misconduct.
Timing...................... Any................. Any.
Setting..................... Routine or emergency Routine or emergency
healthcare in any healthcare in any
setting that setting that
provides human or provides human or
social services, social services,
including in including in
nontraditional nontraditional
settings (e.g., HIV settings (e.g.,
clinics providing school-based
behavioral health clinics providing
care). behavioral health
care).
------------------------------------------------------------------------
Dated: October 27, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-24214 Filed 11-1-23; 8:45 am]
BILLING CODE 4160-90-P